We then examined the in vivo roles of METTL14 in p53‐WT and p53‐MT CRC cells and found that the knockdown of METTL14 increased the tumor volume and weight in p53‐WT tumors but not the p53‐MT ones (Fig 2B and C). This evidence concerns the gene TP53 and colorectal carcinoma.